Find a BV Appraiser
ZipCode or State Advanced Search

BV News and Events

Forecasting, Modeling and Valuation Strategies for Life Science Companies

Jan 03, 2022

Record deal activity within biotech and pharma are warranting a closer look at this specialized asset class. 

Join Ryan Starkes and Charles Higgins of Centri Business Consulting as they look at key VC, IPO and M&A activity; valuation step-up multiples; and overall phase transition success rates. 

View the complete recorded video here

Disclaimer: The views, opinions or examples included in linked article are those of the author and do not necessarily reflect an official policy or position of ASA or its members.